ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.
Clinical trial NCT07680673 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07680673
- Sponsor
- Encellin
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-06
- Primary completion
- 2028-07-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.